These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 29456788)

  • 1. Antroquinonol Exerts Immunosuppressive Effect on CD8
    Guan C; Li Q; Song X; Xu W; Li L; Xu A
    Oxid Med Cell Longev; 2017; 2017():9303054. PubMed ID: 29456788
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IGF-1 resist oxidative damage to HaCaT and depigmentation in mice treated with H
    Guan CP; Li QT; Jiang H; Geng QW; Xu W; Li LY; Xu AE
    Biochem Biophys Res Commun; 2018 Sep; 503(4):2485-2492. PubMed ID: 30208515
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A mouse model of vitiligo with focused epidermal depigmentation requires IFN-γ for autoreactive CD8⁺ T-cell accumulation in the skin.
    Harris JE; Harris TH; Weninger W; Wherry EJ; Hunter CA; Turka LA
    J Invest Dermatol; 2012 Jul; 132(7):1869-76. PubMed ID: 22297636
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacological inhibition of demethylzeylasteral on JAK-STAT signaling ameliorates vitiligo.
    Chang Y; Kang P; Cui T; Guo W; Zhang W; Du P; Yi X; Guo S; Gao T; Li C; Li S
    J Transl Med; 2023 Jul; 21(1):434. PubMed ID: 37403086
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Melanocyte-specific CD8+ T cells are associated with epidermal depigmentation in a novel mouse model of vitiligo.
    You S; Cho YH; Byun JS; Shin EC
    Clin Exp Immunol; 2013 Oct; 174(1):38-44. PubMed ID: 23711243
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antroquinonol differentially modulates T cell activity and reduces interleukin-18 production, but enhances Nrf2 activation, in murine accelerated severe lupus nephritis.
    Tsai PY; Ka SM; Chang JM; Lai JH; Dai MS; Jheng HL; Kuo MT; Chen P; Chen A
    Arthritis Rheum; 2012 Jan; 64(1):232-42. PubMed ID: 21905011
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The therapeutic effects of EGCG on vitiligo.
    Zhu Y; Wang S; Lin F; Li Q; Xu A
    Fitoterapia; 2014 Dec; 99():243-51. PubMed ID: 25128425
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Corrigendum to "Antroquinonol Exerts Immunosuppressive Effect on CD8
    Guan C; Li Q; Song X; Xu W; Li L; Xu A
    Oxid Med Cell Longev; 2020; 2020():1402346. PubMed ID: 33133345
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antroquinonol from ethanolic extract of mycelium of Antrodia cinnamomea protects hepatic cells from ethanol-induced oxidative stress through Nrf-2 activation.
    Kumar KJ; Chu FH; Hsieh HW; Liao JW; Li WH; Lin JC; Shaw JF; Wang SY
    J Ethnopharmacol; 2011 Jun; 136(1):168-77. PubMed ID: 21540101
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Simvastatin prevents and reverses depigmentation in a mouse model of vitiligo.
    Agarwal P; Rashighi M; Essien KI; Richmond JM; Randall L; Pazoki-Toroudi H; Hunter CA; Harris JE
    J Invest Dermatol; 2015 Apr; 135(4):1080-1088. PubMed ID: 25521459
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunosuppressive Effects of
    Hwang YH; Lee SJ; Kang KY; Hur JS; Yee ST
    J Microbiol Biotechnol; 2017 Jun; 27(6):1189-1197. PubMed ID: 28372035
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DCUN1D1, a new molecule involved in depigmentation via upregulating CXCL10.
    Zhao Y; Hu Y; Shen Q; Xiong R; Song X; Guan C
    Exp Dermatol; 2023 Apr; 32(4):457-468. PubMed ID: 36541112
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Therapeutic Effects of Baicalin on Vitiligo Mice.
    Zhu Y; Zhong L; Peng J; Yuan Q; Xu A
    Biol Pharm Bull; 2019 Sep; 42(9):1450-1455. PubMed ID: 31217369
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Renoprotective Effects of Antroquinonol in Rats with N
    Chen JR; Ko J; Yeh WJ; Huang WC; Yang HY
    Nutrients; 2018 Oct; 10(10):. PubMed ID: 30336562
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CCL22 to Activate Treg Migration and Suppress Depigmentation in Vitiligo.
    Eby JM; Kang HK; Tully ST; Bindeman WE; Peiffer DS; Chatterjee S; Mehrotra S; Le Poole IC
    J Invest Dermatol; 2015 Jun; 135(6):1574-1580. PubMed ID: 25634358
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Autoimmune response against tyrosinase induces depigmentation in C57BL/6 black mice.
    Al Robaee AA; Alzolibani AA; Rasheed Z
    Autoimmunity; 2020 Dec; 53(8):459-466. PubMed ID: 33084421
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of TC-1 cytokine production, effector cytotoxic T lymphocyte development and alloantibody production by 2,3,7,8-tetrachlorodibenzo-p-dioxin.
    Kerkvliet NI; Baecher-Steppan L; Shepherd DM; Oughton JA; Vorderstrasse BA; DeKrey GK
    J Immunol; 1996 Sep; 157(6):2310-9. PubMed ID: 8805628
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A similar local immune and oxidative stress phenotype in vitiligo and halo nevus.
    Yang Y; Li S; Zhu G; Zhang Q; Wang G; Gao T; Li C; Wang L; Jian Z
    J Dermatol Sci; 2017 Jul; 87(1):50-59. PubMed ID: 28385330
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A quantitative increase in regulatory T cells controls development of vitiligo.
    Chatterjee S; Eby JM; Al-Khami AA; Soloshchenko M; Kang HK; Kaur N; Naga OS; Murali A; Nishimura MI; Caroline Le Poole I; Mehrotra S
    J Invest Dermatol; 2014 May; 134(5):1285-1294. PubMed ID: 24366614
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pre-clinical evidences of Pyrostegia venusta in the treatment of vitiligo.
    Moreira CG; Carrenho LZ; Pawloski PL; Soley BS; Cabrini DA; Otuki MF
    J Ethnopharmacol; 2015 Jun; 168():315-25. PubMed ID: 25862965
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.